168 related articles for article (PubMed ID: 35452178)
1. Diagnosis, monitoring, and management of pyruvate kinase deficiency in children.
Johnson S; Grace RF; Despotovic JM
Pediatr Blood Cancer; 2022 Aug; 69(8):e29696. PubMed ID: 35452178
[TBL] [Abstract][Full Text] [Related]
2. Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.
Grace RF; Bianchi P; van Beers EJ; Eber SW; Glader B; Yaish HM; Despotovic JM; Rothman JA; Sharma M; McNaull MM; Fermo E; Lezon-Geyda K; Morton DH; Neufeld EJ; Chonat S; Kollmar N; Knoll CM; Kuo K; Kwiatkowski JL; Pospíšilová D; Pastore YD; Thompson AA; Newburger PE; Ravindranath Y; Wang WC; Wlodarski MW; Wang H; Holzhauer S; Breakey VR; Kunz J; Sheth S; Rose MJ; Bradeen HA; Neu N; Guo D; Al-Sayegh H; London WB; Gallagher PG; Zanella A; Barcellini W
Blood; 2018 May; 131(20):2183-2192. PubMed ID: 29549173
[TBL] [Abstract][Full Text] [Related]
3. Pyruvate kinase deficiency in children.
Chonat S; Eber SW; Holzhauer S; Kollmar N; Morton DH; Glader B; Neufeld EJ; Yaish HM; Rothman JA; Sharma M; Ravindranath Y; Wang H; Breakey VR; Sheth S; Bradeen HA; Al-Sayegh H; London WB; Grace RF
Pediatr Blood Cancer; 2021 Sep; 68(9):e29148. PubMed ID: 34125488
[TBL] [Abstract][Full Text] [Related]
4. Updates and advances in pyruvate kinase deficiency.
Luke N; Hillier K; Al-Samkari H; Grace RF
Trends Mol Med; 2023 May; 29(5):406-418. PubMed ID: 36935283
[TBL] [Abstract][Full Text] [Related]
5. Molecular heterogeneity of pyruvate kinase deficiency.
Bianchi P; Fermo E
Haematologica; 2020 Sep; 105(9):2218-2228. PubMed ID: 33054047
[TBL] [Abstract][Full Text] [Related]
6. Consensus document for the diagnosis and treatment of pyruvate kinase deficiency.
Morado M; Villegas AM; de la Iglesia S; Martínez-Nieto J; Del Orbe Barreto R; Beneitez D; Salido E;
Med Clin (Barc); 2021 Sep; 157(5):253.e1-253.e8. PubMed ID: 33431182
[TBL] [Abstract][Full Text] [Related]
7. How we manage patients with pyruvate kinase deficiency.
Grace RF; Mark Layton D; Barcellini W
Br J Haematol; 2019 Mar; 184(5):721-734. PubMed ID: 30681718
[TBL] [Abstract][Full Text] [Related]
8. Management of pyruvate kinase deficiency in children and adults.
Grace RF; Barcellini W
Blood; 2020 Sep; 136(11):1241-1249. PubMed ID: 32702739
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic testing enabled the diagnosis of otherwise undiagnosable cases of pyruvate kinase deficiency.
Chueh HW; Kim N
Pediatr Hematol Oncol; 2022 Mar; 39(2):166-173. PubMed ID: 34281465
[TBL] [Abstract][Full Text] [Related]
10. A Case With Pyruvate Kinase Deficiency Remarkably Sensitive to Heat.
Aksu T; Yarali N; Fermo E; Marcello A; Hacisalihoğlu Ş; Bianchi P; Özbek NY
J Pediatr Hematol Oncol; 2018 Oct; 40(7):e458-e460. PubMed ID: 29309376
[TBL] [Abstract][Full Text] [Related]
11. The Pyruvate Kinase Deficiency Global Longitudinal (Peak) Registry: rationale and study design.
Grace RF; van Beers EJ; Vives Corrons JL; Glader B; Glenthøj A; Kanno H; Kuo KHM; Lander C; Layton DM; Pospíŝilová D; Viprakasit V; Li J; Yan Y; Boscoe AN; Bowden C; Bianchi P
BMJ Open; 2023 Mar; 13(3):e063605. PubMed ID: 36958777
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate kinase activators for treatment of pyruvate kinase deficiency.
Grace RF
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):97-106. PubMed ID: 38066940
[TBL] [Abstract][Full Text] [Related]
13. Hemolytic anemia associated with a novel heterozygote mutation 1183A in the PK-LR gene (PK- Jordan).
Karadsheh NS; Gelbart T; Naffa RG
Int J Lab Hematol; 2014 Aug; 36(4):e66-8. PubMed ID: 24330591
[No Abstract] [Full Text] [Related]
14. Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD.
Schwartz JD; Barcellini W; Grace RF; Bianchi P; Zanella A; López Lorenzo JL; Sevilla J; Shah AJ; Glader B; Nicoletti E; Navarro Ordoñez S; Segovia JC
Am J Hematol; 2022 Mar; 97(3):E120-E125. PubMed ID: 34989415
[No Abstract] [Full Text] [Related]
15. Pyruvate kinase deficiency mimicking congenital dyserythropoietic anemia type I.
Yozgat AK; Erdem AY; Kaçar D; Özbek NY; Yaralı N
Turk J Pediatr; 2022; 64(5):951-955. PubMed ID: 36305449
[TBL] [Abstract][Full Text] [Related]
16. Improving the laboratory diagnosis of pyruvate kinase deficiency.
Laas C; Lambert C; Senior McKenzie T; Sheldon E; Davidson P; Rees D; Clark B
Br J Haematol; 2021 Jun; 193(5):994-1000. PubMed ID: 33937978
[TBL] [Abstract][Full Text] [Related]
17. Tanaka KR, Valentine WN, Miwa S. Pyruvate kinase (PK) deficiency hereditary nonspherocytic hemolytic anemia. Blood. 1962;19(3):267-295.
Blood; 2016 May; 127(21):2505. PubMed ID: 27231390
[No Abstract] [Full Text] [Related]
18. Pyruvate kinase deficiency in a newborn with extramedullary hematopoiesis in the skin.
Voit RA; Grace RF
Blood; 2020 Aug; 136(6):770. PubMed ID: 32761227
[No Abstract] [Full Text] [Related]
19. Erythrocyte pyruvate kinase deficiency: 2015 status report.
Grace RF; Zanella A; Neufeld EJ; Morton DH; Eber S; Yaish H; Glader B
Am J Hematol; 2015 Sep; 90(9):825-30. PubMed ID: 26087744
[TBL] [Abstract][Full Text] [Related]
20. The variable manifestations of disease in pyruvate kinase deficiency and their management.
Al-Samkari H; Van Beers EJ; Kuo KHM; Barcellini W; Bianchi P; Glenthøj A; Del Mar Mañú Pereira M; Van Wijk R; Glader B; Grace RF
Haematologica; 2020 Sep; 105(9):2229-2239. PubMed ID: 33054048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
